These findings indicate an important role for BMP/TGFβ superfamily in the pathogenesis of CML and a potential switch from BMP to Activin A signalling in treatment resistance and progressive disease. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.